Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 pembrolizumab monotherapy study (Japan)
jRCT2080222465Phase 1Completed
- Start
- Apr 2014
- Modality
- Immune Checkpoint Inhibitors → Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, single-arm trial of pembrolizumab in cancer. Started Apr 2014; status: completed.
02
Drugs
03
Conditions
cancer
Beyond the preview
Go deeper on jRCT2080222465.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222465.